Employees Provident Fund Board’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.6M Buy
266,023
+83,642
+46% +$19.5M 0.39% 43
2026
Q1
$44.6M Sell
182,381
-59,203
-25% -$13.8M 0.34% 45
2025
Q4
$50M Buy
241,584
+27
+0% +$5.34K 0.37% 45
2025
Q3
$44.8M Buy
241,557
+11,057
+5% +$1.89M 0.36% 46
2025
Q2
$35.2M Buy
230,500
+131,424
+133% +$20.2M 0.3% 53
2025
Q1
$16.4M Sell
99,076
-15,924
-14% -$2.49M 0.19% 69
2024
Q4
$16.6M Buy
115,000
+26,500
+30% +$4.11M 0.21% 59
2024
Q3
$14.3M Sell
88,500
-7,200
-8% -$1.15M 0.2% 66
2024
Q2
$14M Buy
95,700
+9,200
+11% +$1.37M 0.22% 61
2024
Q1
$13.7M Buy
86,500
+1,500
+2% +$239K 0.24% 59
2023
Q4
$13.3M Buy
85,000
+4,000
+5% +$613K 0.26% 54
2023
Q3
$12.6M Buy
81,000
+21,100
+35% +$3.48M 0.29% 56
2023
Q2
$9.91M Buy
59,900
+9,784
+20% +$1.58M 0.23% 58
2023
Q1
$7.77M Buy
50,116
+34,766
+226% +$5.61M 0.2% 60
2022
Q4
$2.71M Sell
15,350
-1,950
-11% -$337K 0.08% 66
2022
Q3
$2.83M Buy
17,300
+6,600
+62% +$1.12M 0.08% 62
2022
Q2
$1.9M Buy
10,700
+5,500
+106% +$980K 0.04% 77
2022
Q1
$922K Buy
5,200
+1,000
+24% +$170K 0.02% 97
2021
Q4
$718K Buy
+4,200
New +$688K 0.01% 81
2021
Q3
Sell
-285,216
Closed -$47M 70
2021
Q2
$47M Hold
285,216
0.77% 44
2021
Q1
$46.9M Sell
285,216
-95,072
-25% -$15.4M 0.8% 46
2020
Q4
$59.8M Buy
380,288
+18,410
+5% +$2.72M 1.02% 36
2020
Q3
$53.9M Buy
361,878
+22,155
+7% +$3.28M 1.13% 32
2020
Q2
$47.8M Buy
339,723
+253,533
+294% +$36.9M 1.09% 35
2020
Q1
$11.3M Buy
+86,190
New +$12.2M 0.31% 51
2019
Q4
Sell
-54,096
Closed -$7M 57
2019
Q3
$7M Sell
54,096
-400,998
-88% -$52.8M 0.19% 49
2019
Q2
$63.4M Sell
455,094
-163,677
-26% -$22.7M 1.67% 21
2019
Q1
$86.5M Sell
618,771
-28,517
-4% -$3.82M 2.39% 15
2018
Q4
$83.5M Buy
647,288
+79,612
+14% +$11.1M 2.33% 15
2018
Q3
$78.4M Sell
567,676
-346,528
-38% -$46M 2.17% 17
2018
Q2
$111M Buy
914,204
+49,204
+6% +$6.14M 3.01% 10
2018
Q1
$111M Sell
865,000
-55,000
-6% -$7.43M 3.31% 9
2017
Q4
$129M Sell
920,000
-255,037
-22% -$35.5M 3.43% 9
2017
Q3
$153M Buy
1,175,037
+154,191
+15% +$20.4M 4.34% 7
2017
Q2
$135M Sell
1,020,846
-129,876
-11% -$16.6M 3.87% 6
2017
Q1
$143M Buy
1,150,722
+20,810
+2% +$2.49M 4.18% 6
2016
Q4
$130M Buy
1,129,912
+91,111
+9% +$10.5M 4.46% 8
2016
Q3
$123M Buy
1,038,801
+89,920
+9% +$10.9M 4.36% 6
2016
Q2
$115M Sell
948,881
-87,928
-8% -$9.99M 4.9% 6
2016
Q1
$112M Sell
1,036,809
-223,495
-18% -$23.1M 4.79% 6
2015
Q4
$129M Buy
1,260,304
+53,191
+4% +$5.35M 4.43% 6
2015
Q3
$113M Sell
1,207,113
-26,114
-2% -$2.53M 4.28% 5
2015
Q2
$120M Buy
1,233,227
+86,955
+8% +$8.71M 4.21% 5
2015
Q1
$115M Sell
1,146,272
-72,077
-6% -$7.33M 3.92% 4
2014
Q4
$127M Buy
1,218,349
+57,951
+5% +$6.11M 3.9% 5
2014
Q3
$124M Sell
1,160,398
-69,279
-6% -$7.19M 3.9% 4
2014
Q2
$129M Sell
1,229,677
-71,345
-5% -$7.21M 4.06% 4
2014
Q1
$115M Hold
1,301,022
3.71% 6
2013
Q4
$119M Buy
1,301,022
+107,522
+9% +$9.91M 3.6% 6
2013
Q3
$103M Buy
1,193,500
+273,725
+30% +$24.6M 3.73% 6
2013
Q2
$79M Buy
+919,775
New +$78.1M 3.17% 13

Other funds holding JNJ

Employees Provident Fund Board's JNJ Position: Q2 2026 in Review

Employees Provident Fund Board increased its Johnson & Johnson (JNJ) stake by 46% in Q2 2026, buying an estimated $19.5M and bringing the position to 266,023 shares worth $67.6M. The position accounts for 0.39% of the portfolio, ranked #43.

Employees Provident Fund Board first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. The position peaked at $153M in Q3 2017. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Employees Provident Fund Board held 266,023 shares of Johnson & Johnson worth $67.6M as of Q2 2026.
  • Employees Provident Fund Board bought 83,642 Johnson & Johnson shares in Q2 2026, an estimated $19.5M.
  • Johnson & Johnson made up 0.39% of Employees Provident Fund Board's portfolio in Q2 2026, its #43 holding.
  • Employees Provident Fund Board first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
  • Employees Provident Fund Board's Johnson & Johnson position peaked at $153M in Q3 2017.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Employees Provident Fund Board's 13F filing for Q2 2026, filed 12 Aug 2026.